InflaRx N.V. (IFRX)
Official siteHEALTHCARE • BIOTECHNOLOGY • NASDAQ
Market Cap: $172.42M
Last updated: Nov 17, 2026 at 4:10 PM ET
InflaRx N.V. (IFRX) Stock Chart
InflaRx (IFRX) has a latest price of $1.15 on Nov 17, 2026, 61.0% below its 52-week high of $2.95. Its price fell 14.8% over the past 12 months. The month-end price fell 92.2% since Nov 2017, a compound annual decline of 24.9%.
Price Chart
From Nov 2017 to Oct 2026, its highest month-end close was $46.09 in Apr 2019 and its lowest $0.79 in Jun 2025, adjusted for splits.
Month-end closes, adjusted for splits. Dividends are not included.
Chart IFRX with Advanced Charting
Daily candlesticks, valuation multiples, side-by-side comparisons and drawings for IFRX.
Free with a GNG account. No credit card.
Price Performance
Over the past 3 months the price fell 45.8%, and over 6 months it fell 51.5%. The month-end price fell 1.8% over the 3 years through Oct 2026, a compound annual decline of 0.6%.
| Period | Change |
|---|---|
| 1 month | -20.7% |
| 3 months | -45.8% |
| 6 months | -51.5% |
| 12 months | -14.8% |
| 12 months, with dividends | -14.8% |
| Period | Change | Per year |
|---|---|---|
| 3 years | -1.8% | -0.6% |
| 5 years | -60.8% | -17.1% |
| Since Nov 2017 | -92.2% | -24.9% |
Price by Year
Its best calendar year was 2018, when the price rose 73.6%, and its weakest was 2019, when it fell 89.1%.
| Year | Close | Change |
|---|---|---|
| 2026 through Oct 2026 | $1.66 | +64.4% |
| 2025 | $1.01 | -59.1% |
| 2024 | $2.47 | +51.5% |
| 2023 | $1.63 | -47.4% |
| 2022 | $3.10 | -34.9% |
| 2021 | $4.76 | -5.4% |
| 2020 | $5.03 | +27.0% |
| 2019 | $3.96 | -89.1% |
| 2018 | $36.37 | +73.6% |
Trading Range
The price is 30.5% below its 50-day average of $1.65 and 30.7% below its 200-day average of $1.66.
| Measure | Value | Price vs |
|---|---|---|
| Latest price (Nov 17, 2026) | $1.15 | |
| 52-week high | $2.95 | -61.0% |
| 52-week low | $0.80 | +44.1% |
| 50-day average | $1.65 | -30.5% |
| 200-day average | $1.66 | -30.7% |
Price Risk
Over 3 years, its largest fall from a peak was 72.9%.
| Measure | Value |
|---|---|
| 1-year beta | 1.51 |
| Largest fall, 1 year | -58.0% |
| Largest fall, 3 years | -72.9% |
Advanced Charting Features
Advanced Charting is free with a GNG account, and signed-in members get it in place of the price chart above.
- Valuation multiples. Daily P/E, price to sales, cash flow and book value, PEG and PEGY, drawn behind the price wherever the company's data supports them.
- Price charts and drawings. Candlestick, OHLC, line and area charts with volume and earnings, dividend and split markers, plus trend lines, levels and notes kept in your account.
- Side-by-side compare. Two stocks next to each other on one metric and time span, each chart with its own price scale.
- Projections and saved views. Pick a start and an end point to see the price return, dividends and total return between them, and save views to open later.
Frequently Asked Questions About IFRX
What is IFRX's 1-year price change?
InflaRx's price fell 14.8% over the past 12 months. With dividends included, the 12-month total return was -14.8%.
What is IFRX's 5-year price change?
InflaRx's month-end price fell 60.8% over the 5 years through Oct 2026, a compound annual decline of 17.1%. These figures leave out dividends.
What is IFRX's 52-week high and low?
InflaRx's 52-week high is $2.95 and its 52-week low is $0.80. Its latest price of $1.15 on Nov 17, 2026 is 61.0% below the high.
What is IFRX's beta?
InflaRx's 1-year beta against the S&P 500 is 1.51, so its price has moved more than the market over the past year. Its largest fall from a peak over the past year was 58.0%.
Is the IFRX chart free?
Yes. Advanced Charting for IFRX is free with a GNG account, and no credit card is needed. It adds daily candlestick and line charts with volume, valuation multiples, side-by-side comparisons, drawings and saved views.
IFRX pages: Overview, Charting, Financials, Statistics, Competitors